- Home
- KNOP vs LXEO Comparison
KNOP vs LXEO Comparison
Compare KNOP & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- LXEO
- Stock Information
- Founded
- KNOP 2013
- LXEO 2017
- Country
- KNOP United Kingdom
- LXEO United States
- Employees
- KNOP N/A
- LXEO N/A
- Industry
- KNOP Marine Transportation
- LXEO
- Sector
- KNOP Consumer Discretionary
- LXEO
- Exchange
- KNOP Nasdaq
- LXEO Nasdaq
- Market Cap
- KNOP 243.9M
- LXEO 257.0M
- IPO Year
- KNOP 2013
- LXEO 2023
- Fundamental
- Price
- KNOP $8.62
- LXEO $5.18
- Analyst Decision
- KNOP
- LXEO Strong Buy
- Analyst Count
- KNOP 0
- LXEO 7
- Target Price
- KNOP N/A
- LXEO $15.29
- AVG Volume (30 Days)
- KNOP 67.8K
- LXEO 388.3K
- Earning Date
- KNOP 09-25-2025
- LXEO 08-14-2025
- Dividend Yield
- KNOP 1.21%
- LXEO N/A
- EPS Growth
- KNOP N/A
- LXEO N/A
- EPS
- KNOP 0.19
- LXEO N/A
- Revenue
- KNOP $320,026,000.00
- LXEO N/A
- Revenue This Year
- KNOP $9.01
- LXEO N/A
- Revenue Next Year
- KNOP $0.42
- LXEO N/A
- P/E Ratio
- KNOP $47.52
- LXEO N/A
- Revenue Growth
- KNOP 8.76
- LXEO N/A
- 52 Week Low
- KNOP $5.28
- LXEO $1.45
- 52 Week High
- KNOP $9.00
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- KNOP 67.04
- LXEO 63.44
- Support Level
- KNOP $7.74
- LXEO $4.96
- Resistance Level
- KNOP $9.00
- LXEO $5.40
- Average True Range (ATR)
- KNOP 0.36
- LXEO 0.28
- MACD
- KNOP 0.08
- LXEO 0.02
- Stochastic Oscillator
- KNOP 79.12
- LXEO 75.50
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.